Micro-K Extencaps®
Natural health product licensed in Canada
- Licence holder
- Knight Therapeutics Inc.
- NPN or DIN-HM
- 02042304
- Status
- Active licence
- Licence date
- 21 August 2008
- Revision date
- 1 May 2026
- Form
- Capsule
- Route of administration
- Orale
- Application type
- DIN de transition
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Stéarate de magnésium, Acide citrique monohydraté, Ethylcellulose, Hypromellose, Décanedioate de dibutyle, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 5 Capsule ; maximum: 12 Capsule | Not specified |
| Adultes | Not specified | minimum: 2 Capsule ; maximum: 3 Capsule | Not specified |
Uses authorised in Canada
For treatment of potassium depletion. For prevention of hypokalemia.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If abdominal pain, distention, nausea, vomiting or gastrointestinal bleeding occur, discontinue medication immediately and consult your physician. For therapeutic use only. Use only on advise of a physician. Keep out of reach of children. Additional cautions and warnings are included in the product monograph.
- Effets indésirables connus
Known adverse reactions are included in the product monograph.
Source
Official Health Canada record, licence 02042304
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.